{"url":"https://lda.senate.gov/api/v1/filings/ec9ea9eb-b740-44ee-9ebf-e2052e8304fb/","filing_uuid":"ec9ea9eb-b740-44ee-9ebf-e2052e8304fb","filing_type":"4TY","filing_type_display":"4th Quarter - Termination (No Activity)","filing_year":2023,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/ec9ea9eb-b740-44ee-9ebf-e2052e8304fb/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Bruce Heiman, Partner","dt_posted":"2023-11-15T15:32:41-05:00","termination_date":"2023-10-31","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1601 K Street, NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":32098,"url":"https://lda.senate.gov/api/v1/registrants/32098/","house_registrant_id":31355,"name":"K&L GATES, LLP","description":"Law firm","address_1":"1601 K Street, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DINA KERLEY","contact_telephone":"+1 202-661-3767","dt_updated":"2026-07-29T12:32:27.232424-04:00"},"client":{"id":210039,"url":"https://lda.senate.gov/api/v1/clients/210039/","client_id":1009913,"name":"ABPRO CORPORATION","general_description":"Biotechnology company developing next generation antibody therapeutics.","client_government_entity":false,"client_self_select":null,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-04-02"},"lobbying_activities":[],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}